Table of Contents 1 Non-oncology Biopharmaceuticals Market Overview 1.1 Product Overview and Scope of Non-oncology Biopharmaceuticals 1.2 Classification of Non-oncology Biopharmaceuticals by Types 1.2.1 Global Non-oncology Biopharmaceuticals Revenue Comparison by Types (2019-2024) 1.2.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018 1.2.3 Biologics 1.2.4 Biosimilars 1.3 Global Non-oncology Biopharmaceuticals Market by Application 1.3.1 Global Non-oncology Biopharmaceuticals Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Immunology 1.3.3 Endocrinology 1.3.4 Others 1.4 Global Non-oncology Biopharmaceuticals Market by Regions 1.4.1 Global Non-oncology Biopharmaceuticals Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-oncology Biopharmaceuticals Status and Prospect (2014-2024) 1.5 Global Market Size of Non-oncology Biopharmaceuticals (2014-2024) 2 Manufacturers Profiles 2.1 Roche 2.1.1 Business Overview 2.1.2 Non-oncology Biopharmaceuticals Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.2 Sanofi 2.2.1 Business Overview 2.2.2 Non-oncology Biopharmaceuticals Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.3 Johnson & Johnson 2.3.1 Business Overview 2.3.2 Non-oncology Biopharmaceuticals Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Non-oncology Biopharmaceuticals Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.5 Novo Nordisk 2.5.1 Business Overview 2.5.2 Non-oncology Biopharmaceuticals Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.6 Novartis 2.6.1 Business Overview 2.6.2 Non-oncology Biopharmaceuticals Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.7 Merck 2.7.1 Business Overview 2.7.2 Non-oncology Biopharmaceuticals Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.8 Teva 2.8.1 Business Overview 2.8.2 Non-oncology Biopharmaceuticals Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.9 Eli Lilly 2.9.1 Business Overview 2.9.2 Non-oncology Biopharmaceuticals Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.10 Bristol-Myers Squibb 2.10.1 Business Overview 2.10.2 Non-oncology Biopharmaceuticals Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.11 GlaxoSmithKline 2.11.1 Business Overview 2.11.2 Non-oncology Biopharmaceuticals Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.12 UCB Pharma 2.12.1 Business Overview 2.12.2 Non-oncology Biopharmaceuticals Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.13 Amgen 2.13.1 Business Overview 2.13.2 Non-oncology Biopharmaceuticals Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.14 AbbVie 2.14.1 Business Overview 2.14.2 Non-oncology Biopharmaceuticals Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.15 Takeda 2.15.1 Business Overview 2.15.2 Non-oncology Biopharmaceuticals Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.16 AstraZeneca 2.16.1 Business Overview 2.16.2 Non-oncology Biopharmaceuticals Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.17 Mylan 2.17.1 Business Overview 2.17.2 Non-oncology Biopharmaceuticals Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.18 LEO Pharma 2.18.1 Business Overview 2.18.2 Non-oncology Biopharmaceuticals Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.19 Boehringer Ingelheim 2.19.1 Business Overview 2.19.2 Non-oncology Biopharmaceuticals Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.20 Alexion Pharmaceuticals 2.20.1 Business Overview 2.20.2 Non-oncology Biopharmaceuticals Type and Applications 2.20.2.1 Product A 2.20.2.2 Product B 2.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.21 Elusys Therapeutics 2.21.1 Business Overview 2.2.2 Non-oncology Biopharmaceuticals Type and Applications 2.21.2.1 Product A 2.21.2.2 Product B 2.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.22 Swedish Orphan Biovitrum 2.22.1 Business Overview 2.22.2 Non-oncology Biopharmaceuticals Type and Applications 2.22.2.1 Product A 2.22.2.2 Product B 2.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 2.23 Biogen 2.23.1 Business Overview 2.23.2 Non-oncology Biopharmaceuticals Type and Applications 2.23.2.1 Product A 2.23.2.2 Product B 2.23.3 Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) 3 Global Non-oncology Biopharmaceuticals Market Competition, by Players 3.1 Global Non-oncology Biopharmaceuticals Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Non-oncology Biopharmaceuticals Players Market Share 3.2.2 Top 10 Non-oncology Biopharmaceuticals Players Market Share 3.3 Market Competition Trend 4 Global Non-oncology Biopharmaceuticals Market Size by Regions 4.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Regions 4.2 North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 4.3 Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 4.5 South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 5 North America Non-oncology Biopharmaceuticals Revenue by Countries 5.1 North America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) 5.2 USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 5.3 Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 5.4 Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 6 Europe Non-oncology Biopharmaceuticals Revenue by Countries 6.1 Europe Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) 6.2 Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 6.3 UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 6.4 France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 6.5 Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 6.6 Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries 7.1 Asia-Pacific Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) 7.2 China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 7.3 Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 7.4 Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 7.5 India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 8 South America Non-oncology Biopharmaceuticals Revenue by Countries 8.1 South America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) 8.2 Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 8.3 Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 8.4 Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Non-oncology Biopharmaceuticals by Countries 9.1 Middle East and Africa Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) 9.2 Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 9.3 UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 9.4 Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 9.5 Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 9.6 South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) 10 Global Non-oncology Biopharmaceuticals Market Segment by Type 10.1 Global Non-oncology Biopharmaceuticals Revenue and Market Share by Type (2014-2019) 10.2 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2019-2024) 10.3 Biologics Revenue Growth Rate (2014-2024) 10.4 Biosimilars Revenue Growth Rate (2014-2024) 11 Global Non-oncology Biopharmaceuticals Market Segment by Application 11.1 Global Non-oncology Biopharmaceuticals Revenue Market Share by Application (2014-2019) 11.2 Non-oncology Biopharmaceuticals Market Forecast by Application (2019-2024) 11.3 Immunology Revenue Growth (2014-2019) 11.4 Endocrinology Revenue Growth (2014-2019) 11.5 Others Revenue Growth (2014-2019) 12 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024) 12.1 Global Non-oncology Biopharmaceuticals Market Size Forecast (2019-2024) 12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Regions (2019-2024) 12.3 North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) 12.4 Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) 12.6 South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Non-oncology Biopharmaceuticals Picture Table Product Specifications of Non-oncology Biopharmaceuticals Table Global Non-oncology Biopharmaceuticals and Revenue (Million USD) Market Split by Product Type Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Types in 2018 Figure Biologics Picture Figure Biosimilars Picture Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Application (2014-2024) Figure Non-oncology Biopharmaceuticals Revenue Market Share by Applications in 2018 Figure Immunology Picture Figure Endocrinology Picture Figure Others Picture Table Global Market Non-oncology Biopharmaceuticals Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (2014-2024) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Non-oncology Biopharmaceuticals Type and Applications Table Roche Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Non-oncology Biopharmaceuticals Type and Applications Table Sanofi Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Non-oncology Biopharmaceuticals Type and Applications Table Johnson & Johnson Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Non-oncology Biopharmaceuticals Type and Applications Table Pfizer Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Novo Nordisk Basic Information, Manufacturing Base and Competitors Table Novo Nordisk Non-oncology Biopharmaceuticals Type and Applications Table Novo Nordisk Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Non-oncology Biopharmaceuticals Type and Applications Table Novartis Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Non-oncology Biopharmaceuticals Type and Applications Table Merck Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Teva Basic Information, Manufacturing Base and Competitors Table Teva Non-oncology Biopharmaceuticals Type and Applications Table Teva Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Non-oncology Biopharmaceuticals Type and Applications Table Eli Lilly Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Type and Applications Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Non-oncology Biopharmaceuticals Type and Applications Table GlaxoSmithKline Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table UCB Pharma Basic Information, Manufacturing Base and Competitors Table UCB Pharma Non-oncology Biopharmaceuticals Type and Applications Table UCB Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Non-oncology Biopharmaceuticals Type and Applications Table Amgen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table AbbVie Basic Information, Manufacturing Base and Competitors Table AbbVie Non-oncology Biopharmaceuticals Type and Applications Table AbbVie Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Takeda Basic Information, Manufacturing Base and Competitors Table Takeda Non-oncology Biopharmaceuticals Type and Applications Table Takeda Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Non-oncology Biopharmaceuticals Type and Applications Table AstraZeneca Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Mylan Basic Information, Manufacturing Base and Competitors Table Mylan Non-oncology Biopharmaceuticals Type and Applications Table Mylan Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table LEO Pharma Basic Information, Manufacturing Base and Competitors Table LEO Pharma Non-oncology Biopharmaceuticals Type and Applications Table LEO Pharma Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Type and Applications Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Type and Applications Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Elusys Therapeutics Basic Information, Manufacturing Base and Competitors Table Elusys Therapeutics Non-oncology Biopharmaceuticals Type and Applications Table Elusys Therapeutics Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Swedish Orphan Biovitrum Basic Information, Manufacturing Base and Competitors Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Type and Applications Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Biogen Basic Information, Manufacturing Base and Competitors Table Biogen Non-oncology Biopharmaceuticals Type and Applications Table Biogen Non-oncology Biopharmaceuticals Revenue, Gross Margin and Market Share (2017-2018) Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Players (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue Share by Players (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2017 Figure Global Non-oncology Biopharmaceuticals Revenue Share by Players in 2018 Figure Global Top 5 Players Non-oncology Biopharmaceuticals Revenue Market Share in 2018 Figure Global Top 10 Players Non-oncology Biopharmaceuticals Revenue Market Share in 2018 Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Regions (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Market Share by Regions in 2018 Figure North America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Europe Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure South America Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Table North America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) Table North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure North America Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018 Figure USA Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Canada Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Mexico Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Table Europe Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019) Figure Europe Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure Europe Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018 Figure Germany Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure UK Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure France Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Russia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Italy Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Table Asia-Pacific Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018 Figure China Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Japan Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Korea Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure India Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Southeast Asia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Table South America Non-oncology Biopharmaceuticals Revenue by Countries (2014-2019) Table South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure South America Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018 Figure Brazil Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Argentina Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Colombia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Table Middle East and Africa Non-oncology Biopharmaceuticals Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Share by Countries in 2018 Figure Saudi Arabia Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure UAE Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Egypt Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Nigeria Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Figure South Africa Non-oncology Biopharmaceuticals Revenue and Growth Rate (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) by Type (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue Share by Type (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Share by Type (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Share by Type in 2018 Table Global Non-oncology Biopharmaceuticals Revenue Forecast by Type (2019-2024) Figure Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2019-2024) Figure Global Biologics Revenue Growth Rate (2014-2019) Figure Global Biosimilars Revenue Growth Rate (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue by Application (2014-2019) Table Global Non-oncology Biopharmaceuticals Revenue Share by Application (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Share by Application (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue Share by Application in 2018 Table Global Non-oncology Biopharmaceuticals Revenue Forecast by Application (2019-2024) Figure Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2019-2024) Figure Global Immunology Revenue Growth Rate (2014-2019) Figure Global Endocrinology Revenue Growth Rate (2014-2019) Figure Global Others Revenue Growth Rate (2014-2019) Figure Global Non-oncology Biopharmaceuticals Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Non-oncology Biopharmaceuticals Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Non-oncology Biopharmaceuticals Revenue Market Share Forecast by Regions (2019-2024) Figure North America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) Figure Europe Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) Figure Asia-Pacific Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) Figure South America Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024) Figure Middle East and Africa Non-oncology Biopharmaceuticals Revenue Market Forecast (2019-2024)

Roche Sanofi Johnson & Johnson Pfizer Novo Nordisk Novartis Merck Teva Eli Lilly Bristol-Myers Squibb GlaxoSmithKline UCB Pharma Amgen AbbVie Takeda AstraZeneca Mylan LEO Pharma Boehringer Ingelheim Alexion Pharmaceuticals Elusys Therapeutics Swedish Orphan Biovitrum Biogen